Synlett 2006(2): 275-278  
DOI: 10.1055/s-2006-926222
LETTER
© Georg Thieme Verlag Stuttgart · New York

Synthesis of THIQ Derivatives as Potential Boron Neutron Capture Therapy Agents: N-Functionalized o-Carboranylmethyl Benzopiperidines

Chai-Ho Lee*a, Jung Mee Oha, Jong-Dae Leeb, Hiroyukiki Nakamurac, Jaejung Ko*b, Sang Ook Kang*b
a Department of Bionanochemistry and Institute of Basic Natural Science, Wonkwang University, Iksan, Jeonbuk 570-74, South Korea
b Department of Chemistry, Korea University, 208 Seochang, Chungnam 339-700, South Korea
Fax: +82(41)8675396; e-Mail: sangok@korea.ac.kr;
c Department of Chemistry, Faculty of Science, Gakushuin University, Toshima, Tokyo 171-8588, Japan
Further Information

Publication History

Received 28 July 2005
Publication Date:
24 January 2006 (online)

Abstract

A method for synthesizing o-carborane substituted tetrahydroisoquinolines containing a polar functional group such as sulfonic or phosphoric acid on the nitrogen atom of the piperidine ring, starting from N-(2-arylethyl)sulfamic acid or 2-arylethylamidophosphate, is described. In vitro studies showed that the desired compounds 7a and 10b accumulate to high levels in B-16 melanoma cells despite low cytotoxicity.

    References

  • 1a Fauchere J.-L. Leukart O. Eberie A. Schwyzer R. Helv. Chim. Acta  1979,  62:  1385 
  • 1b Leukarr O. Caviezel M. Eberie A. Escher E. Tun-Kyi A. Schwyzer R. Helv. Chim. Acta  1976,  59:  2184 
  • 2 Valliant JF. Guenther KJ. King AS. Morel P. Schaffer P. Sogbein OO. Stephenson KA. Coord. Chem. Rev.  2003,  232:  173 
  • 3a Locher GL. Am. J. Roentgenol. Radium Ther.  1936,  36:  1 
  • 3b Soloway AH. Tjarks W. Barnum BA. Rong FG. Barth RF. Codogni IM. Wilson JG. Chem. Rev.  1998,  98:  1515 
  • 4a Hawthorne MF. Angew. Chem., Int. Ed. Engl.  1993,  32:  950 
  • 4b Morin C. Tetrahedron  1994,  50:  12521 
  • 4c Yamamoto Y. Pure. Appl. Chem.  1991,  63:  423 
  • 4d Barth RF. Soloway AH. Fairchild RG. Cancer Res.  1990,  50:  1061 
  • 5a Lee C.-H. Yang ID. Nakamura H. Ko J. Kang SO. Synlett  2004,  1799 
  • 5b Lee C.-H. Lim HG. Lee JD. Lee YJ. Ko J. Nakamura H. Kang SO. Appl. Organomet. Chem.  2003,  17:  539 
  • 5c Lee JD. Lee C.-H. Nakamura H. Ko J. Kang SO. Tetrahedron Lett.  2002,  43:  5483 
  • 6a Lee JS. Kim SH. Yoon HS. Lee C.-H. Bull. Korean Chem. Soc.  2003,  24:  1041 
  • 6b Shi D.-F. Bradshaw TD. Chua M.-S. Westwell AD. Stevens MF. Bioorg. Med. Chem. Lett.  2001,  11:  1093 
  • 6c Curran WV. Ross AA. Lee VJ. J. Antibiot.  1988,  151:  1418 
  • 7a Lee JD. Lee YJ. Jeong HJ. Lee JS. Lee C.-H. Ko J. Kang SO. Organometallics  2003,  22:  445 
  • 7b Haushalter RC. Butler WM. Rudolph RW. J. Am. Chem. Soc.  1981,  103:  2620 
  • 8a Lee JS. Yang ID. Kim SH. An SI. Lee C.-H. Bull. Korean Chem. Soc.  2003,  24:  129 
  • 8b Lee JS. Lee C.-H. Bull. Korean Chem. Soc.  2002,  23:  167 
  • 8c Lee C.-H. J. Korean Chem. Soc.  1999,  43:  131 
  • 8d Lee C.-H. Kim SH. Chung KW. Kang TW. J. Korean Chem. Soc.  1998,  42:  245 
  • 8e Lee C.-H. Chung YS. Chung BY. Bull. Korean Chem. Soc.  1993,  14:  592 
  • 8f Lee C.-H. Kohn H. J. Org. Chem.  1990,  55:  6098 
  • 8g Lee C.-H. Kohn H. J. Heterocycl. Chem.  1990,  27:  2107 
  • 8h Whaley KW. Govindachari TR. Org. React.  1951,  6:  151 
  • 9a Kannan T. Vinodhkumar S. Varghese B. Loganathan D. Bioorg. Med. Chem. Lett.  2001,  11:  2433 
  • 9b Hammerschmidt F. Hanbauer M. J. Org. Chem.  2000,  65:  6121 
  • 9c Braands KMJ. Wiedbrauk JM. Williams U.-H. Reider PJ. Tetrahedron Lett.  1998,  39:  9583 
  • 10a Silverstein RM. Bassler GC. Morrill TC. Spectrometric Identification of Organic Compounds   4th ed.:  John Wiley and Sons; New York: 1991. 
  • 10b Nakanichi K. Solomon PH. Infrared Absorption Spectroscopy   Holden-Day; San Francisco: 1977. 
  • 11 Tietze LF. Bothe U. Griesbach U. Nakaichi M. Hasegawa T. Nakamura H. Yamamoto Y. ChemBioChem  2001,  2:  326